STOCK TITAN

[SCHEDULE 13D/A] Lamb Weston Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

On 06/28/2025, Roivant Sciences Ltd. (ROIV) Chief Financial Officer Richard Pulik filed a Form 4 disclosing a net share settlement relating to the vesting of restricted stock units (RSUs). To cover tax-withholding obligations, the issuer withheld and disposed of 1,653 common shares at $11.39 per share, coded “F” in Table I. After completing the administrative transaction, Pulik directly owns 399,472 common shares, which includes stock acquired through the company’s Employee Stock Purchase Plan. No derivative security activity was reported.

The filing reflects an internal tax-payment mechanism rather than an open-market sale or purchase, and therefore is unlikely to signal any change in management’s outlook or the company’s fundamentals.

Il 28/06/2025, Richard Pulik, Chief Financial Officer di Roivant Sciences Ltd. (ROIV), ha presentato un Modulo 4 che dichiara un regolamento netto di azioni relativo alla maturazione di unità azionarie vincolate (RSU). Per coprire le obbligazioni fiscali, l'emittente ha trattenuto e venduto 1.653 azioni ordinarie a 11,39 $ per azione, codificate come “F” nella Tabella I. Dopo aver completato questa operazione amministrativa, Pulik detiene direttamente 399.472 azioni ordinarie, comprensive delle azioni acquisite tramite il Piano di Acquisto Azionario per Dipendenti della società. Non sono state segnalate attività su strumenti derivati.

La comunicazione riflette un meccanismo interno di pagamento delle tasse e non una vendita o acquisto sul mercato aperto, pertanto è improbabile che indichi un cambiamento nelle prospettive della direzione o nei fondamentali dell'azienda.

El 28/06/2025, Richard Pulik, Director Financiero de Roivant Sciences Ltd. (ROIV), presentó un Formulario 4 revelando un ajuste neto de acciones relacionado con la consolidación de unidades de acciones restringidas (RSU). Para cubrir las obligaciones fiscales, el emisor retuvo y dispuso de 1,653 acciones comunes a $11.39 por acción, codificadas como “F” en la Tabla I. Tras completar esta transacción administrativa, Pulik posee directamente 399,472 acciones comunes, incluyendo acciones adquiridas a través del Plan de Compra de Acciones para Empleados de la compañía. No se reportaron actividades con valores derivados.

La presentación refleja un mecanismo interno de pago de impuestos y no una venta o compra en el mercado abierto, por lo que es poco probable que indique un cambio en la perspectiva de la dirección o en los fundamentos de la empresa.

2025년 6월 28일, Roivant Sciences Ltd.(ROIV)의 최고재무책임자 리처드 풀릭(Richard Pulik)이 제한 주식 단위(RSU)의 권리 행사와 관련된 순 주식 정산을 공개하는 Form 4를 제출했습니다. 세금 원천징수 의무를 충당하기 위해 발행사는 1,653주 보통주를 주당 $11.39에 보유 및 처분했으며, 이는 표 I에서 “F”로 표시되어 있습니다. 행정 절차 완료 후, 풀릭은 회사의 직원 주식 구매 계획을 통해 취득한 주식을 포함하여 직접 399,472주 보통주를 보유하고 있습니다. 파생 증권 관련 활동은 보고되지 않았습니다.

이번 신고는 공개 시장에서의 매매가 아닌 내부 세금 납부 메커니즘을 반영하므로 경영진의 전망이나 회사의 기본적 상황에 변화가 있음을 시사하지 않을 가능성이 큽니다.

Le 28/06/2025, Richard Pulik, directeur financier de Roivant Sciences Ltd. (ROIV), a déposé un formulaire 4 divulguant un règlement net d’actions lié à l’acquisition des unités d’actions restreintes (RSU). Pour couvrir les obligations fiscales, l’émetteur a retenu et cédé 1 653 actions ordinaires au prix de 11,39 $ par action, codées « F » dans le tableau I. Après cette opération administrative, Pulik détient directement 399 472 actions ordinaires, incluant les actions acquises via le plan d’achat d’actions des employés de la société. Aucune activité sur des titres dérivés n’a été signalée.

Cette déclaration reflète un mécanisme interne de paiement des impôts plutôt qu’une vente ou un achat sur le marché ouvert, et il est donc peu probable qu’elle indique un changement dans les perspectives de la direction ou les fondamentaux de l’entreprise.

Am 28.06.2025 reichte Richard Pulik, Chief Financial Officer von Roivant Sciences Ltd. (ROIV), ein Formular 4 ein, das eine Netto-Aktienabwicklung im Zusammenhang mit der Vesting von Restricted Stock Units (RSUs) offenlegt. Um Steuerabzüge zu decken, behielt der Emittent 1.653 Stammaktien zum Preis von 11,39 $ pro Aktie ein und veräußerte diese, codiert mit „F“ in Tabelle I. Nach Abschluss dieser administrativen Transaktion besitzt Pulik direkt 399.472 Stammaktien, einschließlich Aktien, die über den Mitarbeiteraktienkaufplan des Unternehmens erworben wurden. Es wurden keine Aktivitäten mit derivativen Wertpapieren gemeldet.

Die Meldung spiegelt einen internen Steuerzahlungsmechanismus wider und stellt keinen Kauf oder Verkauf am offenen Markt dar, weshalb sie wahrscheinlich keine Änderung der Managementaussichten oder der Fundamentaldaten des Unternehmens signalisiert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor administrative share withholding; neutral effect on valuation.

The Form 4 documents an F-coded “net settlement” tied to RSU vesting, not an open-market transaction. Only 1,653 shares—about 0.4% of Pulik’s post-transaction stake—were surrendered at $11.39 to satisfy taxes. With 399,472 shares still held, the CFO maintains substantial equity alignment. The absence of derivative activity or sales through a 10b5-1 plan limits market impact.

TL;DR: Routine Section 16 filing; no governance red flags.

This transaction is a standard tax-withholding procedure accompanying RSU settlement and complies with Section 16(a) requirements. There is no indication of strategic insider selling, control shifts, or governance concerns. Consequently, the filing is procedural and carries negligible implications for shareholder rights or board oversight.

Il 28/06/2025, Richard Pulik, Chief Financial Officer di Roivant Sciences Ltd. (ROIV), ha presentato un Modulo 4 che dichiara un regolamento netto di azioni relativo alla maturazione di unità azionarie vincolate (RSU). Per coprire le obbligazioni fiscali, l'emittente ha trattenuto e venduto 1.653 azioni ordinarie a 11,39 $ per azione, codificate come “F” nella Tabella I. Dopo aver completato questa operazione amministrativa, Pulik detiene direttamente 399.472 azioni ordinarie, comprensive delle azioni acquisite tramite il Piano di Acquisto Azionario per Dipendenti della società. Non sono state segnalate attività su strumenti derivati.

La comunicazione riflette un meccanismo interno di pagamento delle tasse e non una vendita o acquisto sul mercato aperto, pertanto è improbabile che indichi un cambiamento nelle prospettive della direzione o nei fondamentali dell'azienda.

El 28/06/2025, Richard Pulik, Director Financiero de Roivant Sciences Ltd. (ROIV), presentó un Formulario 4 revelando un ajuste neto de acciones relacionado con la consolidación de unidades de acciones restringidas (RSU). Para cubrir las obligaciones fiscales, el emisor retuvo y dispuso de 1,653 acciones comunes a $11.39 por acción, codificadas como “F” en la Tabla I. Tras completar esta transacción administrativa, Pulik posee directamente 399,472 acciones comunes, incluyendo acciones adquiridas a través del Plan de Compra de Acciones para Empleados de la compañía. No se reportaron actividades con valores derivados.

La presentación refleja un mecanismo interno de pago de impuestos y no una venta o compra en el mercado abierto, por lo que es poco probable que indique un cambio en la perspectiva de la dirección o en los fundamentos de la empresa.

2025년 6월 28일, Roivant Sciences Ltd.(ROIV)의 최고재무책임자 리처드 풀릭(Richard Pulik)이 제한 주식 단위(RSU)의 권리 행사와 관련된 순 주식 정산을 공개하는 Form 4를 제출했습니다. 세금 원천징수 의무를 충당하기 위해 발행사는 1,653주 보통주를 주당 $11.39에 보유 및 처분했으며, 이는 표 I에서 “F”로 표시되어 있습니다. 행정 절차 완료 후, 풀릭은 회사의 직원 주식 구매 계획을 통해 취득한 주식을 포함하여 직접 399,472주 보통주를 보유하고 있습니다. 파생 증권 관련 활동은 보고되지 않았습니다.

이번 신고는 공개 시장에서의 매매가 아닌 내부 세금 납부 메커니즘을 반영하므로 경영진의 전망이나 회사의 기본적 상황에 변화가 있음을 시사하지 않을 가능성이 큽니다.

Le 28/06/2025, Richard Pulik, directeur financier de Roivant Sciences Ltd. (ROIV), a déposé un formulaire 4 divulguant un règlement net d’actions lié à l’acquisition des unités d’actions restreintes (RSU). Pour couvrir les obligations fiscales, l’émetteur a retenu et cédé 1 653 actions ordinaires au prix de 11,39 $ par action, codées « F » dans le tableau I. Après cette opération administrative, Pulik détient directement 399 472 actions ordinaires, incluant les actions acquises via le plan d’achat d’actions des employés de la société. Aucune activité sur des titres dérivés n’a été signalée.

Cette déclaration reflète un mécanisme interne de paiement des impôts plutôt qu’une vente ou un achat sur le marché ouvert, et il est donc peu probable qu’elle indique un changement dans les perspectives de la direction ou les fondamentaux de l’entreprise.

Am 28.06.2025 reichte Richard Pulik, Chief Financial Officer von Roivant Sciences Ltd. (ROIV), ein Formular 4 ein, das eine Netto-Aktienabwicklung im Zusammenhang mit der Vesting von Restricted Stock Units (RSUs) offenlegt. Um Steuerabzüge zu decken, behielt der Emittent 1.653 Stammaktien zum Preis von 11,39 $ pro Aktie ein und veräußerte diese, codiert mit „F“ in Tabelle I. Nach Abschluss dieser administrativen Transaktion besitzt Pulik direkt 399.472 Stammaktien, einschließlich Aktien, die über den Mitarbeiteraktienkaufplan des Unternehmens erworben wurden. Es wurden keine Aktivitäten mit derivativen Wertpapieren gemeldet.

Die Meldung spiegelt einen internen Steuerzahlungsmechanismus wider und stellt keinen Kauf oder Verkauf am offenen Markt dar, weshalb sie wahrscheinlich keine Änderung der Managementaussichten oder der Fundamentaldaten des Unternehmens signalisiert.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Box 13 - The percentages used herein are calculated based on 141,115,615 shares of common stock, $1.00 par value per share (the "Shares") outstanding as of March 27, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the "SEC") on April 3, 2025 (the "Quarterly Report").


SCHEDULE 13D




Comment for Type of Reporting Person:
Box 11 - Does not include 15 Shares over which Mr. Paul Fribourg does not have direct or indirect beneficial ownership. Such shares are held in a trust for members of Mr. Paul Fribourg's extended family in which Mr. Paul Fribourg is one of three voting trustees. Box 13 - The percentages used herein are calculated based on 141,115,615 Shares outstanding as of March 27, 2025, as disclosed in the Quarterly Report.


SCHEDULE 13D




Comment for Type of Reporting Person:
Box 11 - Ari D. Gendason is the Chief Investment Officer ("CIO") of Continental Grain Company. In his capacity as CIO, Mr. Gendason possesses neither shared nor sole voting or dispositional control over the 2,134,080 Shares beneficially owned by Continental Grain Company. However, as the CIO of Continental Grain Company, there may be certain unforeseen circumstances affecting Continental Grain Company that could result in Mr. Gendason potentially influencing the sale and voting of the 2,134,080 Shares owned by Continental Grain Company. The Reporting Persons do not believe the occurrence of any such unforeseen circumstance to be probable. Mr. Gendason expressly disclaims any beneficial ownership of the 2,134,080 Shares beneficially owned by Continental Grain Company. Box 13 -The percentages used herein are calculated based on 141,115,615 Shares outstanding as of March 27, 2025, as disclosed in the Quarterly Report. Represents less than 0.01 percent.


SCHEDULE 13D




Comment for Type of Reporting Person:
Box 11 - Michael J. Zimmerman is a member of the Board of Directors and the Vice Chairman of Continental Grain Company. In his capacity as Vice Chairman, Mr. Zimmerman possesses neither shared nor sole voting or dispositional control over the 2,134,080 Shares beneficially owned by Continental Grain Company. However, as the Vice Chairman of Continental Grain Company, there may be certain unforeseen circumstances affecting Continental Grain Company that could result in Mr. Zimmerman potentially influencing the sale and voting of the 2,134,080 Shares owned by Continental Grain Company. The Reporting Persons do not believe the occurrence of any such unforeseen circumstance to be probable. Mr. Zimmerman expressly disclaims any beneficial ownership of the 2,134,080 Shares beneficially owned by Continental Grain Company. Box 13 - The percentages used herein are calculated based on 141,115,615 Shares outstanding as of March 27, 2025, as disclosed in the Quarterly Report. Represents less than 0.01 percent.


SCHEDULE 13D




Comment for Type of Reporting Person:
Box 11 - This amount does not include 15 Shares over which Mr. Charles Fribourg does not have direct or indirect beneficial ownership. Such Shares are held in a trust for members of Mr. Charles Fribourg's extended family in which Mr. Charles Fribourg is one of three voting trustees. Mr. Charles Fribourg is a member of the Board of Directors and the Vice Chairman of Continental Grain Company. In his capacity as Vice Chairman, Mr. Charles Fribourg possesses neither shared nor sole voting or dispositional control over the 2,134,080 Shares beneficially owned by Continental Grain Company. However, as the Vice Chairman of Continental Grain Company, there may be certain unforeseen circumstances affecting Continental Grain Company that could result in Mr. Charles Fribourg potentially influencing the sale and voting of the 2,134,080 Shares owned by Continental Grain Company. The Reporting Persons do not believe the occurrence of any such unforeseen circumstance to be probable. Mr. Charles Fribourg expressly disclaims any beneficial ownership of the 2,134,080 Shares beneficially owned by Continental Grain Company. Box 13 - The percentages used herein are calculated based on 141,115,615 Shares outstanding as of March 27, 2025, as disclosed in the Quarterly Report. Represents less than 0.01 percent.


SCHEDULE 13D


CONTINENTAL GRAIN CO
Signature:/s/ Ari D. Gendason
Name/Title:Ari D. Gendason, Chief Investment Officer
Date:07/01/2025
FRIBOURG PAUL J
Signature:By: Jonathan Jacobs, as Attorney-In-Fact, /s/ Paul J. Fribourg
Name/Title:Paul J. Fribourg
Date:07/01/2025
GENDASON ARI DAVID
Signature:By: Jonathan Jacobs, as Attorney-In-Fact, /s/ Ari D. Gendason
Name/Title:Ari D. Gendason
Date:07/01/2025
ZIMMERMAN MICHAEL J
Signature:By: Jonathan Jacobs, as Attorney-In-Fact, /s/ Michael J. Zimmerman
Name/Title:Michael J. Zimmerman
Date:07/01/2025
FRIBOURG CHARLES
Signature:By: Jonathan Jacobs, as Attorney-In-Fact, /s/ Charles Fribourg
Name/Title:Charles Fribourg
Date:07/01/2025

FAQ

What did Roivant CFO Richard Pulik report in the Form 4 dated 07/01/2025?

He disclosed a net settlement of 1,653 common shares to cover tax withholding tied to vested RSUs.

How many Roivant shares were disposed of for tax withholding?

1,653 common shares were withheld and disposed of by the issuer.

At what price were the shares withheld in the transaction?

The shares were valued at $11.39 per share during the net settlement.

How many ROIV shares does the CFO own after the transaction?

Richard Pulik now directly owns 399,472 common shares.

Did the Form 4 involve any open-market sale by the CFO?

No. The filing reflects an administrative tax-withholding event, not an open-market sale.

Were any derivative securities reported in this filing?

No derivative security transactions were reported in Table II.
Lamb Weston Hold

NYSE:LW

LW Rankings

LW Latest News

LW Latest SEC Filings

LW Stock Data

7.51B
136.68M
2.4%
103.17%
7.27%
Packaged Foods
Canned, Frozen & Preservd Fruit, Veg & Food Specialties
Link
United States
EAGLE